Early events regulating post-viral immunopathology
调节病毒后免疫病理学的早期事件
基本信息
- 批准号:9130393
- 负责人:
- 金额:$ 40.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryAntigensAntiviral AgentsAutocrine CommunicationCD8B1 geneCandidate Disease GeneCell DeathCellsComplexDataDiseaseEffector CellElementsEpigenetic ProcessEventExposure toGene ExpressionGenesGoalsHandHealthHistone CodeHistonesHomeostasisHourHumanImmuneImmune responseImmunologicsInfectionInflammationInflammatory ResponseInjuryInterferon Type IInterferonsKineticsKnowledgeLeadLicensingLigandsLungMaintenanceMediatingModelingModificationPatternPeripheralPhasePhenotypePlayPredispositionProcessProductionProteolysisReagentRegulationResolutionRoleSignal TransductionSourceStagingStimulusSynapsesSystemT cell regulationT cell responseT-LymphocyteTNF geneTNFRSF1A geneTestingTimeTissuesTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaVaccinationViralVirusVirus Diseasesautocrineepigenomehistone modificationhuman TNF proteinimmunopathologyinfluenzavirusinterestlung injuryparacrinepathogenprogramsrespiratory infection virusresponsetoxicant
项目摘要
DESCRIPTION (provided by applicant): The controlled contraction of immune responses during the clearance of respiratory virus infection is critical to resolution of inflammation and te limitation of lung injury. The kinetics of antiviral effector CD8+ T cell contraction, and dampenin of effector function, appears to be programmed during the initial activation of naive T cells, and possibly prior. Among other negative regulators of immune responses, it has long been appreciated that TNF-alpha signaling plays an important role in contraction of CD8+ effector T cells, though the precise mechanisms involved remain unclear. We've shown that the critical timing of TNF-programmed contraction occurs within the first 24-48 hours after initial antigen recognition, and plays little immunoregulatory role thereafter. Furthermore, the critical source of
this early burst of TNF production is the naive CD8+ T cell upon initial antigen recognition. We hypothesize that the ability of the naive CD8+ T cell to produce an early TNF burst is critically dependent upon homeostatic type I interferon signaling in the host milieu prior to infection. The IFN-mediated regulation of the early burst of TNF-α by naive CD8+ T cells is quite complex, and appears dependent upon post-thymic peripheral T cell "licensing", during which the impact of constitutive low-level IFN production confers the tendency to mount this important early TNF response. We propose that this involves epigenetic "licensing" of naive T cells for this critical activity. The fundamental hypothesis of this proposal is that signals from the host milieu impinge upon naive CD8+ T cell through epigenetic events, which have a direct impact on the kinetics of the contraction of the T cell responses and effector activities during and after viral infection, serving to limit lung injury and immunopathology.
描述(由申请人提供):清除呼吸道病毒感染期间免疫反应的受控收缩对于消退炎症和限制肺损伤至关重要。抗病毒效应 CD8+ T 细胞收缩的动力学和效应功能的抑制素似乎是在初始 T 细胞的初始激活期间(甚至可能之前)进行编程的。在免疫反应的其他负调节因子中,人们长期以来一直认识到 TNF-α 信号在 CD8+ 效应 T 细胞的收缩中发挥着重要作用,但所涉及的确切机制仍不清楚。我们已经证明,TNF 程序性收缩的关键时机发生在初始抗原识别后的前 24-48 小时内,此后几乎不发挥免疫调节作用。此外,关键来源
这种早期爆发的 TNF 产生是初始抗原识别后的初始 CD8+ T 细胞。我们假设初始 CD8+ T 细胞产生早期 TNF 爆发的能力主要取决于感染前宿主环境中 I 型干扰素稳态信号传导。初始 CD8+ T 细胞对 TNF-α 早期爆发的 IFN 介导调节相当复杂,并且似乎依赖于胸腺后外周 T 细胞的“许可”,在此期间,组成型低水平 IFN 产生的影响赋予了这种重要的早期 TNF 反应的倾向。我们认为这涉及幼稚 T 细胞的表观遗传“许可”,以实现这一关键活动。该提议的基本假设是,来自宿主环境的信号通过表观遗传事件影响初始 CD8+ T 细胞,这对病毒感染期间和之后 T 细胞反应收缩的动力学和效应器活动产生直接影响,从而有助于限制肺损伤和免疫病理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD I ENELOW其他文献
RICHARD I ENELOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD I ENELOW', 18)}}的其他基金
TYPE I INTERFERON REGULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
I 型干扰素对流感肺炎免疫病理学的调节
- 批准号:
8168321 - 财政年份:2010
- 资助金额:
$ 40.5万 - 项目类别:
Innate Regulation of CD8+ T Cell Effector Activites
CD8 T 细胞效应器活性的先天调节
- 批准号:
7746104 - 财政年份:2009
- 资助金额:
$ 40.5万 - 项目类别:
TYPE I INTERFERON REULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
Ⅰ型干扰素对流感肺炎免疫病理学的调节作用
- 批准号:
7959996 - 财政年份:2009
- 资助金额:
$ 40.5万 - 项目类别:
TYPE I INTERFERON REULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
Ⅰ型干扰素对流感肺炎免疫病理学的调节作用
- 批准号:
7720753 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
Interferon-gamma in Experimental Pulmonary Fibrosis
实验性肺纤维化中的干扰素-γ
- 批准号:
6629468 - 财政年份:2002
- 资助金额:
$ 40.5万 - 项目类别:
相似海外基金
Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
- 批准号:
23K07659 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
- 批准号:
23K19490 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
- 批准号:
10697567 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
- 批准号:
10727765 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
- 批准号:
23K13905 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
- 批准号:
23K08467 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
- 批准号:
493138 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
- 批准号:
2223225 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
- 批准号:
10651054 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:














{{item.name}}会员




